Dr. Lou Cen, M.M., Consultant –Nuclear Medicine Physician, Director and Senior Attending of the Nuclear Medicine. Dr. Lou is a master tutor and an editorial board member of the Chinese Journal of Nuclear Medicine and molecular imaging. Currently, she has published more than 30 professional papers and books. She specializes in the treatment of differential thyroid carcinoma, hyperthyroidism and metastatic tumor of bone by internal exposure.

After receiving advanced nuclear medicine training at the International Atomic Energy Agency in 1996, she received her qualification certificate as a Nuclear Medicine Physician. She has also engaged in advanced studies at the American Mayo Clinic Hospital regarding diagnosis and treatment using nuclear medicine in 2010. Thus, she is experienced in ¹³¹I therapy after thyroid carcinoma surgery.

·             ¹³¹I therapy of differential thyroid carcinoma and hyperthyroidism

·             Detection of myocardial viability and gastric emptying function

·             Pulmonary embolism, deep vein thrombosis

·             Location of ectopic gastric mucosa, ectopic thyroid and Sentinel lymph node of tumor

¹³¹I therapy (differential thyroid carcinoma and hyperthyroidism), ⁸⁹Sr therapy (metastatic tumor of bone) and gastrointestinal nuclide imaging combined with a hydrogen breath test (small intestinal bacterial overgrowth)

·             Chinese Society of Nuclear Medicine

·             Committee of Nuclear Medicine Equipment and Technology of Chinese Medical Equipment Association

·             Nuclear Medicine and Radiation Protection Branch of Zhejiang Province Medical Association